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Isolation of genes differentially expressed at 
the downstream anastomosis of prosthetic 
arterial grafts with use of mRNA 
differential display 
Allen D. Hamdan, MD, Lloyd P. Aiello, MD, PhD, William C. Quist, MD, PhD, 
C. Keith Ozaki, MD, Mauricio A. Contreras, MD, Matthew D. Phaneuf, BS, 
Carmen Ruiz, BS, George L. King, MD, and Frank W. LoGerfo, MD, Boston, Mass. 
Purpose: Downstream anastomotic ntimal hyperplasia in prosthetic arterial grafts remains 
a major cause of  delayed graft failure. The new method of messenger RNA (mRNA) 
differential display was used to screen numerous genes to gain insight into the molecular 
mechanisms of  intimal hyperplasia. 
Methods: Fifty-centimeter-long 8 mm expanded polytetrafluoroethylene grafts were 
placed in four mongrel dogs from the carotid artery to the distal abdominal aorta. At 3 
months the distal anastomoses and adjacent normal aortas were harvested; a portion was 
taken for histologic examination, and total RNA was isolated from the remainder. 
Differential mRNA display was used to identify candidate DNA clones whose expression 
differed in anastomotic ntimal hyperplasia s compared with adjacent unaffected aorta. 
The clones were sequenced, and national gene databases were searched. Northern blot 
analysis confirmed alteration of  gene expression. 
Results: Approximately 5000 mRNA species were screened, and n candidate clones were 
obtained. DNA sequence revealed homology of  five clones to known gene sequences. 
Homologous genes included an interferon-gamma-induced human gene, ( IGUP 1-5111), 
alpha-1 proteas e inhibitor gene, human retinoblastoma susceptibility gene, and human 
creatine kinase gene (two clones). Northern blot analysis revealed altered gene expression 
in 4 of  11, nonregulation i 1 of  11, and undetectable signals in 6 of  11. Expression of  
the clone representing IGUP 1-5111 in the segment of  intimal hyperplasia was found to 
be decreased over threefold to only 31% - 16.4% SE of the level seen in normal aorta. 
Conclusions: The technique of mRNA differential display has identified ifferences in gene 
expression in an in vivo model of  anastomotic intimal hyperplasia. Expression of  RNA 
with homology to an interferon-gamma-induced human gene was consistently decreased 
within the hyperplastic region at the downstream polytetrafluoroethylene arterial 
anastomosis. (J VASC SURG 1995;21:228-34.) 
Anastomotic ntimal hyperplasia remains amajor 
cause of prosthetic arterial graft failure. 1,2 Hyperpla- 
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sia tends to be greatest at the downstream anasto- 
mosis and is independent o f  the graft material, s,4 
Intimal hyperplasia occurs after all forms o f  vascular 
injury, such as balloon catheter denudation, angio- 
plasty, endarterectomy, or placement o f  a vascular 
graft, where it occurs as anastomotic intimal 
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hyperplasia. 4-6 Numerous previous reports have de- 
fined the structure and progression of these lesions, 
which involve migration and proliferation of smooth 
muscle cells. The hyperplastic lesions consist of 
smooth muscle cells, mostly of the synthetic type, 
although some are of the transitional or quiescent 
type. At approximately 3 months after the initial 
inciting event, a steady state is apparently reached 
where the ~morphous matrix comprises approxi- 
mately 80% of the intimal volume. 5,7,8 Based on 
previous tudies, some of the molecules mediating 
this response may include platelet-derived growth 
factor, basic fibroblast growth factor, and angiotensin 
I I .  9 .n  However, multiple additional factors are prob- 
ably involved in this complex phenomenon. In 
general, the development of intimal hyperplasia 
probably results from a disruption of the balance 
between inhibitory and stimulatory factors. 12 
We have used the new technique of mRNA 
differential display to evaluate the differences in gene 
expression between two tissues, in this case, an area 
of anastomotic ntimal hyperplasia and the adjacent 
normal aorta. Once the differences ingene expression 
are identified, it is possible to isolate, amplify, and 
sequence the gene. Ultimately this may lead to 
identification of the gene product and elucidation of 
its role in intimal hyperplasia. Therefore this new 
technology is a promising tool for identifying the 
molecular mechanisms involved in the pathogenesis 
of intimal hyperplasia. 
MATERIAL AND METHODS 
Four mongrel dogs weighing 20 to 25 kg were 
used. Animal care complied with the "Principles of 
Laboratory Animal Care" (formulated by the Na- 
tional Society for Medical Research) and the Guide for 
the Care and Use of Laboratory Animals (NIH 
Publication No. 86-23, revised 1985). Expanded 
polytetrafluoroethylene (ePTFE) grafts were ob- 
tained from W.L. Gore & Associates, Inc. (Elkton, 
Md.). Enzymes were purchased from GIBCO BRL 
(Bethesda, Md.) unless indicated otherwise. Phos- 
phorus 32-labeled eoxyadensine triphosphate (rip_ 
dATP), sulfur 35-labeled deoxyadensine triphos- 
phate (3SS-dATP), and sulfur 35-labeled eoxycyti- 
dine triphosphate (35S-dCTP) were obtained from 
Dupont/NEN (Dupont/New England Nuclear, Wil- 
mington, Del.). Superscript reverse transcriptase was 
purchased from Invitrogen (San Diego, Calif.). 
Polymerase chain reactions (PCR) were performed in
Costar 96-well polycarbonate plates (Costar, Cam- 
bridge, Mass.) in an American Analytical Omnigene 
thermocycler with use of AmpliTaq DNA poly- 
merase and PCR buffer from Perkins-Ceres (Nor- 
walk, Colin.). PCR primers were obtained from 
Operon Technologies, Inc. (Alameda, Calif.). 
Prosthetic grafts. With the dogs under general 
anesthesia, 50 cm long 8 mm (internal diameter) 
ePTFE grafts were placed in four mongrel dogs as 
described previously) 3 Briefly, the abdominal aorta 
was isolated via a left retroperitoneal approach, the 
distal anastomosis was performed, and the graft was 
tunneled subcutaneously into the neck. The proximal 
anastomosis was to the left common carotid artery. 
The proximal aorta and the distal carotid artery were 
then ligated to create preferential flow through the 
graft. Patency of the graft was easily established 
through direct palpation and Doppler examination~ 
Three months after reconstruction the anastomoses 
were harvested, and the animal was killed. A portion 
of the distal anastomosis (graft and aorta) was 
retained for confirmatory histologic analysis. Five- 
micrometer sections were stained with hematoxylin- 
eosin and Verhoeff's elastic stains. The remaining 
vessel was proportioned into segments hat paralleled 
those sent to histology and immediately frozen in 
liquid nitrogen and stored at -80  ° C before total 
RNA isolation. 
Differential display. Differential display was 
performed as per previous tudies (Fig. 1). ~4-16 Total 
RNA was isolated from the tissue specimen with use 
of the acid-guanidium-thiocyanate technique and 
phenol-chloroform extraction.17 The maximum zone 
of intimal hyperplasia, identified by gross examina- 
tion, was found at the suture line and approximately 
2 cm into the PTFE graft. The control sample was 
taken 4 cm distal to the anastomotic site. The aorta 
proximal to the anastomosis was not used in any of 
the experimental protocol. These grossly defined 
sample sites were then confirmed by histologic 
examination. Total RIgA was isolated independently 
from these regions. Deoxyribonuclease was added to 
25 txg RNA in the presence of pancreatic ribonu- 
clease inhibitor (Gibco BILL) to remove any DNA 
contaminant. Phenol-chloroform extraction was per- 
formed before ethanol precipitation. Reverse tran- 
scription (RT) reactions were performed for each 
RNA sample with 0.2 ~xg of DNA free-total RNA in 
1 x RT buffer (Gibco BRL), 10 mmol/L dithiothrei- 
tol, 20 txm each of deoxyguanosine triphosphate 
(dGTP), dATP, dCTP, and deoxythymidine triphos- 
phate (dTTP), and 1 txmol/L of either T12NG or 
T~2NC oligonucleotide where N is threefold egen- 
erate for G, A, and C: ~8 
JOURNAL OF VASCULAR SURGERY 



























Fig. 1. Differential display method: total RNA from either hyperplastic zone or normal artery 
was isolated. With use of poly-T primer that recognizes poly-A tails unique to message RNA, 
cDNA clones were made with use of reverse transcriptase. These clones were then amplified by 
PCR with use of same poly-T primer and another arbitrary but specific primer that will allow 
creation of discrete segments of cDNA. cDNA clones are then separated on polyacrylamide g l 
by size (number of base pairs). As indicated, band that is absent in hyperplasia l ne as compared 
with control ane suggests hat this gene's expression is decreased in hyperplasia. Conversely, 
gene that is absent in control ane indicates possible increase in hyperplasia. 
PCR was performed in 96-well polycarbonate 
plates. Reactions contained 0.1 volume RT reaction, 
1 x PCR buffer (Perkins Cetus, Norwalk, Conn.), 
4 txmol/L each of dGTP, dTTP, and dCTP, 2 ~tm 
dATP, 10 IxCi 3SS-dATP, 1 b~mol/L of the respective 
T12NX oligonudeotide, 0.2 txmol/L specific arbitrary 
i0 base pair primer and 10 units AmpliTaq DNA 
polymerase. Light mineral oil (Sigma, St. Louis, 
Mo.) was overlaid, and 40 cycles of PCR were 
performed as previously described. 16DNA sequenc- 
ing stop buffer (U.S. Biochemical, Inc., Cleveland, 
Ohio) was added to each sample and heated to 
80 ° C x 2 min before loading on 6% polyacrylamide 
sequencing el. A number of arbitrary 10-mer were 
screened against T~2NC or T~2NG RT products 
from both zones with differential display. Identical 
reactions with use of separate RT reaction products 
were run side by side on the gel for confirmation. Gels 
were run at 65 W constant current, dried without 
fixation, and exposed irectly to Kodak XAR-5 film 
(Eastman Kodak Co., Rochester, N.Y.) for 24 to 48 
hours at room temperature. 
Band recovery. Bands demonstrating reproduc- 
ible differences were excised under sterile conditions 
as described previously. 16 Reamplification by PCR 
was performed with use of the appropriate primers 
and conditions noted above, except for deoxyribo- 
nucleoside triphosphate concentrations of 25 
ixmol/L and no radioisotope. After visualization with 
ethidium bromide, DNA was excised from 2% 
agarose gels and eluted with use of polyethylene spin 
columns. 19 The eluent was used directly for probe 
generation and subcloning. 
Subcloning. The TA Cloning Kit (lnvitrogen 
Version 1.3; Invitrogen) was used for all subcloning 
reactions. Ligation products were transformed into 
competent Escherichia coli and plated for kanamycin 
resistance. White or light blue colonies were selected, 
and the alkaline lysis miniprep was used for isolation 
of plasmids. 2° The presence of an insert was con- 
firmed by ethidium bromide staining after estriction 
enzyme digestion and 2% agarose gel electrophore- 
sis. The plasmids were used for DNA sequencing and 
creation of riboprobe after template linearization. 
Sequencing. Sequencing reactions were per- 
formed in 96-well polycarbonate plates with use of 
Sequenase 2.0 Kit (U.S. Biochemical Corp.), S 3~- 
dATP, SP6, and T7 primers. Products were run on a 
6% polyacrylamide gel made with glycerol tolerant 
buffer, dried, and exposed as per above. Gene 
database searches were performed through the Na- 
tional Center for Biotechnology Information with 
use of the BLAST network service) 1 
Northern blot analysis. Radioactive probes were 
generated with use of Amersham Multiprime label- 
ing kits (Amersham Corp. Arlington Heights, Ill.) 
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Fig. 2. Composite light micrograph depicts distal anastomosis between ePTFE graft and aorta. 
Intimal hyperplasia is grossly visible on graft surface at time of excision. This histologic 
confirmation depicts proliferative growth above internal elastic lamina (arrow) with extension 
across anastomotic line into ePTFE graft. Inset (top right) demonstrates hyperplasia to be 
composed of spindle-shaped cells with abundant extracellular matrix. Distal aorta (top left) is 
composed of spindle-shaped smooth muscle cells organized in lamellar pattern interposed in 
between elastic fibers without proliferation above internal elastic lamina. Open rectangle depicts 
transition from intimal hyperplasia to right, and unaffected aorta to left. Control segments were 
taken separately and distal to this "hyperplastic" segment. 
and 32p-ATP. Northern blot analysis was performed 
with use of formaldehyde denaturing gel electro- 
phoresis, Biotrans nylon membranes (ICN Bio- 
chemicals, Irvine, Calif.), 22 and ultraviolet cross- 
linked by use of a Statagene UV Statalinker 2400 
(Stratagene, La lolla, Calif.). Blots were prehybrid- 
ized and hybridized (1 × 106 cpm/ml) per manufac- 
turer instructions and washed in 0.5 SSC (NaC1, 
NaCit), 5% sodium dodecyl sulfate at 65 ° C with 
four changes over 1 hour. Signals were analyzed with 
use of a Molecular Dynamics PhosphorImager (Mo- 
lecular Dynamics, Sunnyvale, Calif.). Lane-loading 
differences were normalized with 36B4 complimen- 
tary DNA (cDNA) probe. 14,1s,23 
RESULTS 
The distal anastomoses were examined, and zones 
of intimal hyperplasia nd morphologically normal 
aorta were identified histologically (Fig. 2). Total 
RNA was then isolated from the histopathologically 
proven segments containing either normal artery or 
hyperplasia. A total of  20 arbitrary primers were 
used, and each differential display lane yielded 150 to 
250 discrete bands. 16 Thus an estimated 5000 
mRNA species were screened. This represents 25% 
to 50% of the estimated 10,000 to 20,000 cellular 
genes expressed at any given time,18,24 The gels were 
examined for discrete bands that were present in one 
condition and either completely absent or markedly 
diminished in the other (Fig. 3). Only banding 
differences that were confirmed by two separate 
RT/PCR reactions were chosen. In this manner, 11 
bands were isolated and reamplified with PCR. DNA 
sequence analysis demonstrated that all clones were 
180 to 300 base pair in length, five had significant 
homology to previously identified genes, and five had 
no similarity to previously reported genes. Two of the 
inserts appeared to be homologous to the same gene 
at different locations. The previously identified genes 
that showed significant homology to these clones at 
a nucleotide level were an interferon-gamma (INF- 
~)-induced human gene (IGUP 1-5111), 2s alpha-1 
protease inhibitor gene, human creatinine kinase 
gene, and human retinoblastoma susceptibiliu ~ gene. 
Total RNA from three separate animals was used for 
Northern analysis of all putative clones. Loading 
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Fig. 3. Section of differential display gel is shown in left panel with band representing altered 
expression between control (C) and intimal hyperplasia (14) samples noted by solid arrowhead. 
DNA sequencing showed that this band was highly homologous to interferon-gamma-induced 
human gene (IGUP). Open arrowheads mark multiple bands expressed under both conditions. 
Upper ight panel demonstrates Northern blot analysis of IGUP expression between control (C) 
and intimal hyperplasia (H) samples from two dogs (1,2). Lane loading differences were 
normalized by rehybridizing same blots with 36B4 control probe as shown in lower ight panel. 
Relative positions of 28S and 18S ribosomal RNA are indicated. 
differences were normalized by comparison to 36B4, 
a stable ribosomal RNA (Fig. 3). In four of 11 clones, 
altered gene expression was observed, whereas six 
signals were not detectable by Northern blot analysis, 
presumably because of low message number. One 
clone revealed variable expression between three 
separate dogs, thus not confirming regulation at this 
point. In particular, alteration of expression was 
confirmed for a clone that showed 83% homology to 
IGUP I-5111 at the nucleotide level. In three separate 
canine grafts, its expression i  the segment ofintimal 
hyperplasia was decreased threefold to only 
31% _+ 16.4% SE of that observed in normal aorta 
(see Fig. 3). Of  the other clones revealing altered 
expression, two clones with novel sequences showed 
a mild decrease in timal hyperplasia, one clone with 
98% homology to alpha-1 protease inhibitor gene at 
the nucleotide level showed a moderate decrease in 
intimal hyperplasia, and one clone with homology to 
human retinoblastoma susceptibility did not demon- 
strate consistent regulation as stated above. 
DISCUSSION 
Differential display is a powerful technique that 
has made it possible to screen large numbers of genes 
quickly and effectively. Briefly, after total RNA is 
isolated from the respective tissues, mRNA species 
arc selectively transcribed into eDNA by usc of 
reverse transcriptase and primer sequences that rec- 
ognize the polyadenylated tail characteristic of 
mRNA. The eDNA sequences are then amplified in 
the polymerase chain reaction, and run on a poly- 
acrylamide sequencing el to allow banding differ- 
ences to be examined. Some of the advantages of this 
technique are that it can be applied to tissue from in 
vivo models, is not limited to cell culture, and is much 
faster and uses much less material than molecular 
tools used previously. The goal is to identify alter- 
ations in gene expression that will lead to a better 
understanding of intimal hyperplasia nd ultimately 
guide specific treatment. Possible scenarios that could 
lead to the development ofhyperplasia nclude loss of 
a supprcssor molecule required to maintain arterial 
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wall homeostasis and the quiescent state of normal 
smooth muscle cells, elaboration of a proliferative 
factor that is not or is only minimally expressed inthe 
normal artery, a change in the ratio of normally 
expressed genes leading to a biochemical imbalance 
and subsequent disease, or secretion of extracellular 
matrix with altered composition. In this study we 
screened a large portion of the total gene pool and 
isolated 11 candidate molecules, of which four of the 
clones were found to have alteration i  expression by 
Northern blot analysis, whereas seven did not. 
Failure to colffirm altered expression by Northern 
blot analysis was due to undetectable signals (pre- 
sumably resulting from low message l vels) or, in one 
instance, inconsistent expression. In related studies, 
the use of polyadenylated RNA Northern blots 
helped to identify 20% of previously undetectable 
signals. 16 Because of the limited nature of our tissue 
sources in this model, similar mRNA evaluation on 
this select material could not be performed. Altered 
expression was noted in two of five of the clones with 
sequence homology to previously known molecules 
and in two of six of those with novel sequences. A 
clone with no homology to a known gene can occur 
if no similar genes have previously been sequenced. 
Because differential display generatcs small probes in 
the 3' untranslated region, which is poorly conserved 
among species, it is also possible that the homologous 
coding segments may not be present. All changes in 
gene expression must be confirmed by Northern blot 
analysis before definitive conclusions can be made. In 
the case of a novel sequence with a reproducible and 
significant change, further evaluation is indicated. 
This would involve generating a full-length copy of 
the cDNA, including the entire coding and 3' 
noncoding regions, which may then allow for se- 
quence recognition. 
The clone showing DNA sequence homology to 
a IFN-y-induced human gene, IGUP I-5111, dem- 
onsttated decreased xpression i intimal hyperplasia 
as compared with normal aorta in all dogs studied. 
Whether this decrease in gene expression correlates 
with alterations in protein levels remains to be 
evaluated once specific antibodies become available. 
IGUP 1-5111 was originally identified in a kerati- 
nocyte cell culture system. 2s Its stimulation was 
highly specific for IFN-y and its expression was not 
altered by other mitogens, including basic fibroblast 
growth factor, interleukin-1 and both IFN-~ and 
IFN-[3. 2s In intimal hyperplasia t is possible that this 
molecule plays a role in maintaining the nonprolif- 
erative state of the intima and media and, when 
decreased, allows for some of the changes noted in 
hyperplasia. Indeed, IFN-y has been shown to 
decrease smooth muscle cell proliferation in celt 
culture, suggesting that the inducible gene may be a 
mediator of this effect. 26y  In the case of the API 
homologous clone, a decrease in its expression could 
lead to increased activity of proteases, ubsequent 
changes in the matrix and in the ability of smooth 
muscle cells to migrate. Protease activity has been 
shown to be increased in areas of atherosclerotic 
plaque and vessel wall remodeling. 28,29 Our results 
indicate that at least part of this activity may be due 
to decreased expression of this protease inhibitor. 
Identification of altered gene activity in intimal 
hyperplasia provides ameans of directly investigating 
the molecular mechanisms involved in this process. It 
also provides a foundation for a detailed analysis of 
the response to injury of the arterial wall. To 
complete this understanding will require additional 
screening in an attempt o identif T all genes with 
altered expression. Ultimately, identifying the role of 
these genes may allow us to understand the mecha- 
nisms involved and prevent or mitigate the develop-. 
ment of hyperplasia. 
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